Skip to content

A study on the efficacy of NM191 (developmental code)

A study on the efficacy of NM191 (developmental code) - A study on the efficacy of NM191 (developmental code)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000036289
Enrollment
200
Registered
2019-03-29
Start date
2019-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults suffer from stress

Interventions

Ingestion of NM191 (development code) at bed time once a day for 4 weeks Ingestion of placebo beverages at bed time once a day for 4 weeks

Sponsors

Kao Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy males and females of whom the score of the Brief Job Stress Questionnaire (BJSQ) and the Athens Insomnia Scale (AIS) are above the third quartile of the total BJSQ scores and 6 points of AIS, respectively.

Exclusion criteria

Exclusion criteria: - Pregnancies and lactations - Subjects with systemic illness -Individuals prescribed with sleeping medicines - Individuals who can't stop taking a large amount of coffee during the test period - Individuals deemed inappropriate to participate in this study by the principle investigator

Design outcomes

Primary

MeasureTime frame
Comparative evaluation of objective sleep efficiency and subjective indicators of the sleep quality with OSA sleep inventory between before and after the intervention.

Secondary

MeasureTime frame
Score on the Brief Job Stress Questionnaire, autonomic nervous index with heart rate variability, biochemical components in blood, saliva and skin surface lipid before and after the intervention

Countries

Japan

Contacts

Public ContactTakaya Suganuma

Kao Corporation Biological Science Research

suganuma.takaya@kao.com+81-285-68-7538

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026